中原內配(002448.SZ):聯營企業靈動飛揚獲增資700萬元
格隆匯9月23日丨中原內配(002448.SZ)公佈,為滿足公司聯營企業靈動飛揚業務發展需要,解決經營資金需求,經靈動飛揚2020年度股東會決議審議通過,其現有股東以增資擴股的形式對目標公司進行增資,增資金額共計人民幣700萬元,對應新增註冊資本人民幣700萬元。
其中:中原內配增資580萬元,對應新增註冊資本人民幣580萬元;創始股東陸如楓、夏宇、唐旭、吳培民、楊進潮分別向目標公司增資人民幣40萬元、30萬元、30萬元、10萬元、10萬元,對應新增註冊資本人民幣40萬元、30萬元、30萬元、10萬元、10萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.